Put together, we hypothesize that the inactivation of ezrin is linked to a transition towards a solid-like behavior of the cytoskeleton and a reduced ability of the cell to move its nucleus through a crowded extracellular environment, which, in the case of cancer, would hinder malignant cells from migrating through their host tissue. The gene discussed is EZR; the disease is cancer.